ArticleInvestigational new drugs2023

A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors.

Gerald S Falchook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.